Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort.

MLA

Zecca, Erika, et al. “Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort.” Viruses, vol. 14, no. 8, Aug. 2022. EBSCOhost, https://doi.org/10.3390/v14081766.

APA

Zecca, E., Rizzi, M., Tonello, S., Matino, E., Costanzo, M., Rizzi, E., Casciaro, G. F., Manfredi, G. F., Acquaviva, A., Gagliardi, I., Calzaducca, E., Mallela, V. R., D’Onghia, D., Minisini, R., Bellan, M., Castello, L. M., Gavelli, F., Avanzi, G. C., Patrucco, F., … Sainaghi, P. P. (2022). Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort. Viruses, 14(8). https://doi.org/10.3390/v14081766

Chicago

Zecca, Erika, Manuela Rizzi, Stelvio Tonello, Erica Matino, Martina Costanzo, Eleonora Rizzi, Giuseppe Francesco Casciaro, et al. 2022. “Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort.” Viruses 14 (8). doi:10.3390/v14081766.